Chronic Venous Insufficiency Pipeline: Therapeutic
Chronic Venous Insufficiency typically refers to lower extremity edema, skin trophic changes, and discomfort secondary to venous hypertension....
Source: globenewswire.com
Key Pharma Players News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Key Pharma Players. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Key Pharma Players Today - Breaking & Trending Today
Respiratory Syncytial Virus Infection Pipeline: Insights
50+ active players in the domain working on 50+ pipeline therapies. Key Respiratory Syncytial Virus Infection Pipeline therapies such as RSV-F, V-306, CodaVax-RSV, mRNA-1345, MV-012-968, RV521, BARS13, EDP-938, MEDI8897, RSV MAT, RSVpreF, JNJ-53718678, RSV vaccine, ALVR106, V-306, CodaVax-RSV, mRNA-1345, Research program: sirtuin targeted therapeutics for respiratory viral infections and others are under different phases of clinical trials for Respiratory Syncytial Virus (RSV). Virometix, ReViral Ltd, Advaccine (Suzhou) Biopharmaceuticals Co., Ltd. Codagenix, Inc, ModernaTX, Inc., Meissa Va...
Source: globenewswire.com